Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

GE Healthcare Life Sciences completes transition into Cytiva

As Danaher’s $21bn acquisition completes, GE Life Sciences rebrands to ‘Cytiva’ and, with the COVID-19 pandemic, its CEO tells us demand is high.

First US patient receives plasma therapy for coronavirus

FDA grants approval for the use of donated plasma from a recovered COVID-19 patient to be infused into a critically ill patient.

Avectas partners with Vycellix to speed cell therapy production

The partners will combine expertise to progress the novel RNA immunomodulator, VY-M.

J&J chooses lead coronavirus candidate, sets up manufacturing for 1 billion doses

The company provides update on its coronavirus plans, which includes $1bn in funding to research and expected Phase I trial commencement date.

Novartis’ gene therapy takes additional step towards EU approval

Zolgensma has received a recommendation for approval despite running into problems recently, including manufacturing questions and data integrity issues.

Global Industry News

Hot Topics

Spotlight

Latest industry developments against COVID-19

Takeda taps Evox for exosome therapeutics

Gates Foundation in ‘unprecedented’ coronavirus partnership with industry

Astellas and CytomX team up to target solid tumors with T-cells

BioStem adds R&D laboratory space to Florida site

Products

Webinars

On-demand webinars

Marken Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Marken